Earnings announcements are critical events for investors, providing insights into a company's financial health. A delay can lead to uncertainty and speculation, often resulting in short-term stock price volatility. For Autolus Therapeutics, this delay might raise concerns about potential issues or uncertainties within the company, leading to negative investor sentiment in the short term.